Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 6/2005

01-07-2005 | Original Articles

Biochemotherapy with low doses of subcutaneous interleukin-2 in patients with melanoma: results of a phase II trial

Authors: María González Cao, Susana Puig, Josep Malvehy, Josep Eugeni Herrero, Rosa María Martí, Carlos Conill, Marcelo Sánchez, Begoña Mellado, Pere Gascón, Teresa Castel

Published in: Clinical and Translational Oncology | Issue 6/2005

Login to get access
Metadata
Title
Biochemotherapy with low doses of subcutaneous interleukin-2 in patients with melanoma: results of a phase II trial
Authors
María González Cao
Susana Puig
Josep Malvehy
Josep Eugeni Herrero
Rosa María Martí
Carlos Conill
Marcelo Sánchez
Begoña Mellado
Pere Gascón
Teresa Castel
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 6/2005
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02710171

Other articles of this Issue 6/2005

Clinical and Translational Oncology 6/2005 Go to the issue

News

News

Case Reports

Carcinosarcoma de la mama: un tumor de histogénesis controvertida

Review

Liposomal cytarabine (DepoCyte®) for the treatment of neoplastic meningitis

Editorial

Changing strategies in surgical treatment of colorectal liver metastases: state of the art

Educational Review

Ewing’s sarcoma family of tumors

Case Reports

Pseudomembranous colitis associated with chemotherapy with 5-fluorouracil
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits